Paper38071243
The aryl hydrocarbon receptor controls mesenchymal stromal cell-mediated immunomodulation via ubiquitination of eukaryotic elongation factor-2 kinase.
Lkhagva-Yondon E and 10 others. Cell Death Dis, 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. The aryl hydrocarbon receptor controls mesenchymal stromal cell-mediated immunomodulation via ubiquitination of eukaryotic elongation factor-2 kinase. Papers, record 38071243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38071243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The aryl hydrocarbon receptor controls mesenchymal stromal cell-mediated immunomodulation via ubiquitination of eukaryotic elongation factor-2 kinase.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Aryl Hydrocarbon | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Elongation Factor 2 Kinase | |
| Ubiquitination | |
| Immunomodulation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NRF-2016K2A9A2A15003486 | National Research Foundation of Korea (NRF) | PubMed | ||
| NRF-2018R1A2B6005861 | National Research Foundation of Korea (NRF) | PubMed | ||
| NRF-2022R1A2C1010354 | National Research Foundation of Korea (NRF) | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17392787 | Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. | Nature | 2007 | https://conductscience.org/library/papers/17392787 | PubMed |
| 2 | 25690886 | Aryl hydrocarbon receptor mediates both proinflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia. | Glia | 2015 | https://conductscience.org/library/papers/25690886 | PubMed |
| 3 | 9144159 | Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9144159 | PubMed |
| 4 | 8386634 | Regulation of elongation factor-2 by multisite phosphorylation. | Eur J Biochem | 1993 | https://conductscience.org/library/papers/8386634 | PubMed |
| 5 | 20376308 | A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation. | PLoS One | 2010 | https://conductscience.org/library/papers/20376308 | PubMed |
| 6 | 19486938 | Inhibition of human mesenchymal stem cell-derived adipogenesis by the environmental contaminant benzo(a)pyrene. | Toxicol In Vitro | 2009 | https://conductscience.org/library/papers/19486938 | PubMed |
| 7 | 16985180 | Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. | Blood | 2007 | https://conductscience.org/library/papers/16985180 | PubMed |
| 8 | 18468541 | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. | Lancet | 2008 | https://conductscience.org/library/papers/18468541 | PubMed |
| 9 | 2037042 | Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes. | FEBS Lett | 1991 | https://conductscience.org/library/papers/2037042 | PubMed |
| 10 | 25657351 | The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. | Pharmacol Rev | 2015 | https://conductscience.org/library/papers/25657351 | PubMed |
| 11 | 23233726 | Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection. | J Immunol | 2013 | https://conductscience.org/library/papers/23233726 | PubMed |
| 12 | 29610153 | Signaling Pathways Involved in the Regulation of mRNA Translation. | Mol Cell Biol | 2018 | https://conductscience.org/library/papers/29610153 | PubMed |
| 13 | 30739199 | Translational control in brain pathologies: biological significance and therapeutic opportunities. | Acta Neuropathol | 2019 | https://conductscience.org/library/papers/30739199 | PubMed |
| 14 | 22430947 | Mechanism for dynamic regulation of iNOS expression after UVB-irradiation. | Mol Carcinog | 2013 | https://conductscience.org/library/papers/22430947 | PubMed |
| 15 | 26561548 | Aryl Hydrocarbon Receptor Protects Lungs from Cockroach Allergen-Induced Inflammation by Modulating Mesenchymal Stem Cells. | J Immunol | 2015 | https://conductscience.org/library/papers/26561548 | PubMed |
| 16 | 3386756 | Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. | Nature | 1988 | https://conductscience.org/library/papers/3386756 | PubMed |
| 17 | 18371435 | Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. | Cell Stem Cell | 2008 | https://conductscience.org/library/papers/18371435 | PubMed |
| 18 | 34499523 | Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor. | Annu Rev Pharmacol Toxicol | 2022 | https://conductscience.org/library/papers/34499523 | PubMed |
| 19 | 31653699 | Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARγ for proteasomal degradation. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31653699 | PubMed |
| 20 | 2390990 | Functional properties of phosphorylated elongation factor 2. | Eur J Biochem | 1990 | https://conductscience.org/library/papers/2390990 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42581963 | Aryl hydrocarbon receptor regulates programmed cell death in diseases: molecular mechanisms and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42581963 | PubMed |
| 41732254 | PCMTD1-127aa suppresses osteosarcoma progression by competitively binding to USP10 to promote c-MYC degradation. | iScience | 2026 | https://conductscience.org/library/papers/41732254 | PubMed |
| 41540003 | The aryl hydrocarbon receptor: structure, signaling, physiology and pathology. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41540003 | PubMed |
| 41257286 | Preconditioning with StemRegenin 1 enhances human adipose stromal/stem cells proliferation, migration, and protection against antimycin A. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/41257286 | PubMed |
| 40841367 | Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40841367 | PubMed |
| 40517136 | USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40517136 | PubMed |
| 40515888 | Mesenchymal Stromal Cells and Graft-versus-Host Disease: Preclinical and Clinical Studies. | Stem Cell Rev Rep | 2025 | https://conductscience.org/library/papers/40515888 | PubMed |
| 40342843 | Role of the Aryl Hydrocarbon Receptor in the Self-Renewal, Differentiation, and Immunomodulation of Adult Stem Cells. | Immune Netw | 2025 | https://conductscience.org/library/papers/40342843 | PubMed |
| 40157458 | Suppression of global protein synthesis and hepatocellular carcinoma cell growth by Benzimidazoisoquinoline, 4,11-Dichloro-BBQ. | Biochem Pharmacol | 2025 | https://conductscience.org/library/papers/40157458 | PubMed |
| 39495340 | Unveiling the Immune effects of AHR in tumors: a decade of insights from bibliometric analysis (2010-2023). | Discov Oncol | 2024 | https://conductscience.org/library/papers/39495340 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AHR | 196 | PubTator's text mining | https://conductscience.org/library/genes/196 | NCBI Gene |
| CUL4B | 8450 | PubTator's text mining | https://conductscience.org/library/genes/8450 | NCBI Gene |
| EEF2K | 29904 | PubTator's text mining | https://conductscience.org/library/genes/29904 | NCBI Gene |
| NOS2 | 4843 | PubTator's text mining | https://conductscience.org/library/genes/4843 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38071243
GET https://conductscience.org/api/papers/v1/38071243/references?page=2